RecruitingNCT03269630

New Orleans Pulmonary Hypertension Biobank


Sponsor

Louisiana State University Health Sciences Center in New Orleans

Enrollment

450 participants

Start Date

Dec 29, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure \>=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary Hypertension Center OR
  • Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary Hypertension Center OR
  • Diagnosis of mixed connective tissue disease and followed at the Comprehensive Pulmonary Hypertension Center OR
  • Undergoing outpatient right heart catheterization

Exclusion Criteria5

  • Age\<18
  • Pregnant
  • Unable to understand English
  • Currently incarcerated
  • Unwilling or unable to sign informed consent

Interventions

OTHERNo intervention. Biospecimen collection only

Biospecimen collection


Locations(1)

University Medical Center-New Orleans

New Orleans, Louisiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03269630


Related Trials